Frontier Biotechnologies Inc. (SHA:688221)
China flag China · Delayed Price · Currency is CNY
20.42
+1.20 (6.24%)
At close: Mar 10, 2026

Frontier Biotechnologies Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
7,6496,7613,6563,7166,4656,688
Upgrade
Market Cap Growth
97.68%84.94%-1.61%-42.53%-3.33%-3.43%
Upgrade
Enterprise Value
7,3316,4433,4423,0555,3915,318
Upgrade
Last Close Price
20.4218.059.769.9217.2618.59
Upgrade
PS Ratio
53.2447.0628.2432.5276.29165.12
Upgrade
PB Ratio
7.796.893.202.773.873.65
Upgrade
P/TBV Ratio
9.017.973.693.344.574.26
Upgrade
EV/Sales Ratio
51.0344.8526.5926.7463.61131.30
Upgrade
Debt / Equity Ratio
0.380.380.360.280.170.16
Upgrade
Net Debt / Equity Ratio
-0.32-0.32-0.39-0.42-0.58-0.65
Upgrade
Net Debt / EBITDA Ratio
1.321.321.731.862.734.19
Upgrade
Net Debt / FCF Ratio
--2.321.422.242.08
Upgrade
Asset Turnover
--0.070.050.030.02
Upgrade
Inventory Turnover
--1.911.421.471.91
Upgrade
Quick Ratio
--2.812.654.643.76
Upgrade
Current Ratio
--3.092.905.073.95
Upgrade
Return on Equity (ROE)
-24.66%-24.66%-16.21%-21.83%-20.38%-13.36%
Upgrade
Return on Assets (ROA)
---8.76%-9.45%-10.08%-7.95%
Upgrade
Return on Capital Employed (ROCE)
---19.50%-19.60%-18.70%-15.10%
Upgrade
Earnings Yield
-3.42%-3.87%-5.51%-8.85%-5.52%-3.89%
Upgrade
FCF Yield
---5.23%-10.67%-6.64%-8.53%
Upgrade
Buyback Yield / Dilution
-0.26%-0.26%0.24%-2.69%-0.79%-25.23%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.